DOD Pancreatic Cancer, Idea Development Award
ID: 353862Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353862
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 29, 2024 12:00 AM
  4. 4
    Due Oct 3, 2024 12:00 AM
Description

The Department of the Army -- USAMRAA is offering a grant opportunity titled "DOD Pancreatic Cancer, Idea Development Award". This grant aims to support the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. The grant seeks to fund projects that make important and original contributions to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for patients. The research should be innovative and may challenge existing paradigms or utilize new perspectives, methods, or technologies. The grant encourages the inclusion of personnel with experience in pancreatic cancer research and the use of preliminary data to support the proposed research. Additionally, the grant offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. The deadline for application submission is October 3, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
FY24 PCARP Academic Statement.pdf
4/30/2024
HT942524PCARPIDA_GG.pdf
4/30/2024
Similar Opportunities
DOD Pancreatic Cancer, Focused Pilot Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Pancreatic Cancer, Focused Pilot Award". This grant aims to support impactful and innovative concepts in pancreatic cancer research that can lead to significant advancements in patients' overall quality of life. The grant is focused on two patient-centered areas of research: access to healthcare and mental health/cancer-related outcomes and quality of life. The grant encourages studies on behaviors affecting access to healthcare, correlations between mental health and cancer outcomes, strategies to overcome psycho-social issues, behavioral studies on quality of life and decision-making, and development of nutritional or educational interventions for symptom management. The grant does not require preliminary data but expects a well-formulated, testable hypothesis based on strong scientific rationale. Clinical research studies are allowed, but interventional clinical trials, basic research, and preclinical animal studies are not supported. The proposed research should have a significant impact on improving outcomes and quality of life for individuals with pancreatic cancer. Innovation in study concept, research methods or technology, and adaptations of existing methods or technologies is highly encouraged. The grant has an estimated total program funding of $1,280,000 and expects to make 4 awards. The closing date for applications is October 3, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DOD Pancreatic Cancer, Translational Research Partnership Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant opportunity titled "DOD Pancreatic Cancer, Translational Research Partnership Award". This grant aims to support partnerships between clinicians and research scientists to accelerate the translation of promising ideas in pancreatic cancer towards clinical applications. The Translational Research Partnership Award seeks to foster collaborations between two independent investigators to address a central problem or question in pancreatic cancer that would be difficult to achieve through separate efforts. One partner in the collaboration must be a research scientist, while the other partner must be a clinician investigator. The award encourages the inclusion of experts from outside the pancreatic cancer field. The proposed projects should demonstrate the potential to have a significant impact on pancreatic cancer research and/or patient care. They should also leverage clinical information to address knowledge gaps, validate research findings, expand upon transformative results, and investigate novel findings. The application should provide evidence of the reciprocal transfer of information between basic and clinical science. The Translational Research Partnership Award requires the availability of necessary specimens, data, and/or interventions. Preliminary data relevant to pancreatic cancer and the proposed research project are required, although they do not necessarily need to be derived from studies of pancreatic cancer. The success of the project relies on the unique skills and contributions of each partner, and the proposed study must include plans for communication, coordination of research progress and results, and data transfer. This grant opportunity has an estimated total program funding of $4,800,000 and expects to make four awards. The closing date for applications is October 3, 2024. For more information and application submission requirements, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By providing a comprehensive summary of this federal grant notice, we hope to support potential applicants in understanding the purpose and requirements of the DOD Pancreatic Cancer, Translational Research Partnership Award.
DoD Kidney Cancer, Idea Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Kidney Cancer, Idea Development Award". This grant aims to support innovative ideas and high-impact approaches to eliminate kidney cancer. The research project should have a well-formulated hypothesis based on strong scientific rationale and a well-developed research approach. The grant emphasizes the importance of personnel with a strong background in kidney cancer research. The funding instrument for this grant is a grant, and there is no cost sharing or matching requirement. The estimated total program funding is $18.56 million, and approximately 13 awards are expected to be granted. The closing date for applications is October 15, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org.
DoD Peer Reviewed Cancer, Idea Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Peer Reviewed Cancer, Idea Award". This grant aims to support innovative and high-risk concepts, theories, paradigms, and basic cancer research. The funding of $16,000,000 is expected to result in approximately 20 awards. The Idea Award is specifically designed to encourage research that introduces new paradigms, challenges existing ones, and offers highly creative approaches to cancer research. It is not intended to support incremental advances or logical progressions of established projects. The proposed research should have a well-formulated, testable hypothesis based on strong scientific rationale and study design, and generate robust preliminary data. Inclusion of preliminary data is discouraged as this award focuses on exploratory research. Researchers are encouraged to select the most appropriate funding opportunity for their proposed research. For more information, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. The deadline for submission is September 26, 2024, and the archive date is October 26, 2024.
DoD Rare Cancers, Idea Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Rare Cancers, Idea Development Award". This grant aims to promote new ideas in the early stages of development that have the potential to yield impactful data and new avenues of investigation for rare cancers. The grant supports research with preliminary data that could lead to critical discoveries or major advancements in eradicating deaths and suffering from rare cancers. The grant encourages innovative research involving nuclear medicine and related techniques to improve diagnosis, treatment, and health outcomes for active-duty Service Members and their Families. It also encourages research on health areas and conditions that affect women uniquely or differently from men. The grant does not allow clinical trials and emphasizes adherence to rigorous study design and reporting standards. Applications from investigators within the military services and collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs, and other federal government agencies are highly encouraged. The close date for this grant opportunity is September 26, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.